NEO NeoGenomics, Inc. - Common Stock
Sobre NeoGenomics, Inc. - Common Stock Visão geral da empresa da Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Ler mais
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
NEO Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
NEO Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
NEO Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 4 25,0%
- Compra 7 43,8%
- Manter 5 31,2%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
9 analistas · 2026-08-14Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $0.05 | $0.03 | 0.02% |
| 31 de Março de 2026 | $0.01 | $0.01 | 0.00% |
| 31 de Dezembro de 2025 | $0.06 | $0.04 | 0.02% |
| 30 de Setembro de 2025 | $0.03 | $0.02 | 0.01% |
| 30 de Junho de 2025 | $0.03 | $0.02 | 0.01% |
| 31 de Março de 2025 | $0.00 | $-0.01 | 0.01% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Balanço Patrimonial 29
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Fluxo de Caixa 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Balanço Patrimonial 27
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Fluxo de Caixa 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Avaliação (TTM) 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $727M | $661M | $592M | $510M | $484M |
| Margem Bruta % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Margem Operacional % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Lucro líquido | $-108M | $-79M | $-88M | $-144M | $-8M |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.4 | 0.6 | — | — | — |
| Índice de liquidez corrente | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Índice de Liquidez Seca | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-22M | $-34M | $-31M | $-97M | $-91M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 300 declarantes · $1.8B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 64 (+22 vs trimestre anterior) | 38 (+1 vs trimestre anterior) | 93 (+20 vs trimestre anterior) | 59 (-26 vs trimestre anterior) | +33.5M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179.158.241 | 12.279.523 | 9,76% | Ações |
| VANGUARD GROUP INC | $150.953.759 | 12.836.204 | 8,22% | Ações |
| FIRST TRUST ADVISORS LP | $147.552.477 | 10.113.261 | 8,04% | Ações |
| Greenhouse Funds LLLP | $125.097.724 | 8.574.210 | 6,82% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.615.272 | 8.061.362 | 6,41% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.082.418 | 5.763.017 | 4,58% | Ações |
| STATE STREET CORP | $78.257.609 | 5.363.784 | 4,26% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73.501.000 | 5.037.787 | 4,00% | Ações |
| BRAIDWELL LP | $71.756.567 | 4.918.202 | 3,91% | Ações |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61.886.083 | 4.342.883 | 3,37% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50.558.727 | 3.465.300 | 2,75% | Opção de compra |
| MILLENNIUM MANAGEMENT LLC | $44.930.518 | 3.079.542 | 2,45% | Ações |
| TORONTO DOMINION BANK | $43.770.000 | 3.000.000 | 2,38% | Opção de compra |
| GEODE CAPITAL MANAGEMENT, LLC | $42.933.596 | 2.942.009 | 2,34% | Ações |
| Driehaus Capital Management LLC | $36.604.049 | 2.508.845 | 1,99% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34.896.129 | 2.391.784 | 1,90% | Ações |
| AMERICAN CAPITAL MANAGEMENT INC | $32.648.145 | 2.237.707 | 1,78% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $32.593.724 | 2.233.977 | 1,78% | Ações |
| UBS Group AG | $32.581.659 | 2.233.150 | 1,78% | Opção de compra |
| LOOMIS SAYLES & CO L P | $30.838.504 | 2.113.674 | 1,68% | Ações |
| Aberdeen Group plc | $28.180.950 | 1.931.525 | 1,54% | Ações |
| D. E. Shaw & Co., Inc. | $27.938.858 | 1.914.932 | 1,52% | Ações |
| GLENMEDE TRUST CO NA | $20.985.657 | 1.438.359 | 1,14% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.689.018 | 1.212.407 | 0,96% | Ações |
| SEGALL BRYANT & HAMILL, LLC | $15.850.518 | 1.086.396 | 0,86% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $12.685.640 | 869.475 | 0,69% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $11.918.848 | 816.919 | 0,65% | Ações |
| SAMLYN CAPITAL, LLC | $11.869.359 | 813.527 | 0,65% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $11.707.337 | 802.422 | 0,64% | Ações |
| Glenmede Investment Management, LP | $11.359.995 | 1.471.502 | 0,62% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $9.141.555 | 626.563 | 0,50% | Ações |
| HighMark Wealth Management LLC | $8.936.871 | 612.534 | 0,49% | Ações |
| JUPITER ASSET MANAGEMENT LTD | $7.841.935 | 537.487 | 0,43% | Ações |
| Public Sector Pension Investment Board | $6.526.545 | 447.330 | 0,36% | Ações |
| Trexquant Investment LP | $6.358.074 | 435.783 | 0,35% | Ações |
| GOLDMAN SACHS GROUP INC | $5.559.884 | 381.075 | 0,30% | Ações |
| Bank of New York Mellon Corp | $5.554.938 | 380.736 | 0,30% | Ações |
| Granite Investment Partners, LLC | $5.181.507 | 355.141 | 0,28% | Ações |
| RHUMBLINE ADVISERS | $4.624.054 | 316.935 | 0,25% | Ações |
| AMERIPRISE FINANCIAL INC | $4.623.822 | 316.917 | 0,25% | Ações |
| Weiss Asset Management LP | $4.171.558 | 285.919 | 0,23% | Ações |
| Swiss National Bank | $3.800.695 | 260.500 | 0,21% | Ações |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3.770.056 | 258.400 | 0,21% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.680.109 | 252.235 | 0,20% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.455.481 | 236.839 | 0,19% | Ações |
| FMR LLC | $3.409.026 | 233.655 | 0,19% | Ações |
| Squarepoint Ops LLC | $3.239.505 | 222.036 | 0,18% | Ações |
| ExodusPoint Capital Management, LP | $3.128.811 | 214.449 | 0,17% | Ações |
| Legal & General Group Plc | $2.907.700 | 199.294 | 0,16% | Ações |
| PEAK6 LLC | $2.651.003 | 181.700 | 0,14% | Opção de compra |
| FEDERATED HERMES, INC. | $2.510.064 | 172.040 | 0,14% | Ações |
| BANK OF AMERICA CORP /DE/ | $2.221.357 | 152.252 | 0,12% | Ações |
| WHITE PINE CAPITAL LLC | $2.167.184 | 148.539 | 0,12% | Ações |
| PRUDENTIAL FINANCIAL INC | $2.017.870 | 138.305 | 0,11% | Ações |
| AMERICAN CENTURY COMPANIES INC | $1.987.158 | 136.200 | 0,11% | Ações |
| BlackRock, Inc. | $1.962.691 | 134.523 | 0,11% | Ações |
| WELLS FARGO & COMPANY/MN | $1.943.067 | 133.178 | 0,11% | Ações |
| STEELHEAD PARTNERS LLC | $1.885.028 | 129.200 | 0,10% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $1.787.859 | 122.540 | 0,10% | Ações |
| Greenhouse Funds LLLP | $1.689.522 | 115.800 | 0,09% | Opção de compra |
| PERKINS CAPITAL MANAGEMENT INC | $1.605.483 | 110.040 | 0,09% | Ações |
| GABELLI FUNDS LLC | $1.597.605 | 109.500 | 0,09% | Ações |
| ARISTEIA CAPITAL, L.L.C. | $1.571.343 | 107.700 | 0,09% | Ações |
| IEQ CAPITAL, LLC | $1.524.305 | 104.476 | 0,08% | Ações |
| Verition Fund Management LLC | $1.477.019 | 101.235 | 0,08% | Ações |
| GAMCO INVESTORS, INC. ET AL | $1.459.000 | 100.000 | 0,08% | Ações |
| Fernwood Investment Management, LLC | $1.453.536 | 88.200 | 0,08% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.440.244 | 194.103 | 0,08% | Ações |
| XTX Topco Ltd | $1.413.552 | 96.885 | 0,08% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.403.354 | 96.186 | 0,08% | Ações |
| CITADEL ADVISORS LLC | $1.324.772 | 90.800 | 0,07% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.279.178 | 87.675 | 0,07% | Ações |
| Curi Capital, LLC | $1.256.666 | 86.132 | 0,07% | Ações |
| MFG WEALTH MANAGEMENT, INC. | $1.217.711 | 83.462 | 0,07% | Ações |
| ALLIANCEBERNSTEIN L.P. | $1.189.723 | 160.340 | 0,06% | Ações |
| MetLife Investment Management, LLC | $1.120.293 | 76.785 | 0,06% | Ações |
| Mariner, LLC | $1.117.405 | 76.587 | 0,06% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.039.421 | 71.242 | 0,06% | Ações |
| TWO SIGMA ADVISERS, LP | $983.136 | 83.600 | 0,05% | Ações |
| Russell Investments Group, Ltd. | $967.068 | 66.283 | 0,05% | Ações |
| VOYA INVESTMENT MANAGEMENT LLC | $962.429 | 65.965 | 0,05% | Ações |
| MORGAN STANLEY | $954.638 | 65.431 | 0,05% | Ações |
| Quantinno Capital Management LP | $945.359 | 64.795 | 0,05% | Ações |
| Illinois Municipal Retirement Fund | $932.520 | 63.915 | 0,05% | Ações |
| WINTON GROUP Ltd | $924.700 | 63.379 | 0,05% | Ações |
| Quantbot Technologies LP | $922.540 | 63.231 | 0,05% | Ações |
| CHOREO, LLC | $889.115 | 60.940 | 0,05% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884.373 | 60.615 | 0,05% | Ações |
| MOODY NATIONAL BANK TRUST DIVISION | $860.445 | 58.975 | 0,05% | Ações |
| Louisiana State Employees Retirement System | $833.089 | 57.100 | 0,05% | Ações |
| SIMPLEX TRADING, LLC | $796.453 | 54.589 | 0,04% | Ações |
| JANE STREET GROUP, LLC | $786.401 | 53.900 | 0,04% | Opção de compra |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786.109 | 53.880 | 0,04% | Ações |
| Teton Advisors, LLC | $774.729 | 53.100 | 0,04% | Ações |
| Invesco Ltd. | $766.515 | 52.537 | 0,04% | Ações |
| COMMERCE BANK | $764.632 | 52.408 | 0,04% | Ações |
| Vanguard Global Advisers, LLC | $741.070 | 50.793 | 0,04% | Ações |
| BARD ASSOCIATES INC | $683.761 | 46.865 | 0,04% | Ações |
| Alamea Verwaltungs GmbH | $683.702 | 46.861 | 0,04% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $674.467 | 46.228 | 0,04% | Ações |
Executivos da empresa 52 insiders · 30 diretores · 23 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 1 de Junho de 2025 M | 20.166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 23 de Fevereiro de 2025 M | 641.585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 1 de Março de 2022 A | 368.051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 11 de Maio de 2025 M | 168.332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 28 de Abril de 2022 M | 191.548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 1 de Março de 2019 A | 10.944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 23 de Fevereiro de 2024 A | 148.455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 1 de Agosto de 2022 A | 43.216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 2 de Março de 2022 F | 244.157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 1 de Março de 2022 A | 33.443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 30 de Dezembro de 2021 A | 41.280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 25 de Maio de 2021 M | 150.101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 11 de Maio de 2025 M | 108.280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 1 de Setembro de 2025 F | 47.940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 23 de Fevereiro de 2025 M | 109.755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 1 de Abril de 2023 F | 82.673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 2 de Março de 2023 F | 29.765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 1 de Abril de 2022 A | 158.684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 1 de Março de 2022 A | 147.396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 11 de Janeiro de 2022 M | 49.361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 30 de Dezembro de 2021 A | 48.615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 22 de Abril de 2021 M | 130.847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 2 de Março de 2021 A | 60.643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 22 de Outubro de 2018 M | 45.953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 10 de Maio de 2018 X | 4.500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 25 de Maio de 2017 A | 60.692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 28 de Janeiro de 2016 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 29 de Dezembro de 2015 X | 51.218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 22 de Maio de 2014 X | 8.439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 18 de Maio de 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Conselheiro | 23 de Junho de 2026 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Conselheiro | 15 de Junho de 2026 S | 86.115 | 0 | 2 | $-118.824 |
| Marjorie C Green | Conselheiro | 1 de Junho de 2026 A | 22.964 | 0 | 0 | $0 |
| Neil Gunn | Conselheiro | 1 de Junho de 2026 A | 51.177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Conselheiro | 1 de Junho de 2026 A | 67.086 | 0 | 0 | $0 |
| David Brian Perez | Conselheiro | 1 de Junho de 2026 A | 56.967 | 0 | 0 | $0 |
| John P. Kenny | Conselheiro | 1 de Junho de 2026 A | 5.893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Conselheiro | 1 de Junho de 2026 A | 75.421 | 0 | 0 | $0 |
| Felicia Williams | Conselheiro | 1 de Junho de 2026 A | 30.237 | 0 | 0 | $0 |
| Elizabeth Floegel | Conselheiro | 1 de Junho de 2025 A | 23.590 | 0 | 0 | $0 |
| Alison L. Hannah | Conselheiro | 1 de Junho de 2025 M | 131.023 | 0 | 0 | $0 |
| Bruce K Crowther | Conselheiro | 10 de Agosto de 2023 A | 65.120 | 0 | 0 | $0 |
| Rachel A Stahler | Conselheiro | 10 de Junho de 2022 A | 21.335 | 0 | 0 | $0 |
| David Daly | Conselheiro | 10 de Junho de 2022 A | 17.179 | 0 | 0 | $0 |
| Kevin C Johnson | Conselheiro | 22 de Dezembro de 2021 M | 37.398 | 0 | 0 | $0 |
| Douglas M Van Oort | Conselheiro | 1 de Agosto de 2021 F | 2.468.797 | 0 | 0 | $0 |
| Steven C Jones | Conselheiro | 7 de Janeiro de 2021 M | 90.218 | 0 | 0 | $0 |
| Raymond R Hipp | Conselheiro | 16 de Novembro de 2020 S | 66.800 | 0 | 0 | $0 |
| William J Robison | Conselheiro | 25 de Maio de 2017 A | 183.348 | 0 | 0 | $0 |
| Michael T Dent | Conselheiro | 4 de Dezembro de 2014 S | 1.384.150 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 12 de Abril de 2007 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 62 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,12% | 167.212 SH | 8 de Agosto de 2026 | Diário |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,09% | 113.008 SH | 8 de Agosto de 2026 | Diário |
| LFSC · RBB Fund, Inc. | 0,43% | 43.071 NS | 31 de Maio de 2026 | N-PORT |
| IHF · iShares Trust | 0,31% | 243.554 SH | 8 de Agosto de 2026 | Diário |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 154.408 NS | 30 de Abril de 2026 | N-PORT |
| IJT · iShares Trust | 0,13% | 700.692 SH | 8 de Agosto de 2026 | Diário |
| XJR · iShares Trust | 0,13% | 15.435 SH | 8 de Agosto de 2026 | Diário |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,12% | 19.262 SH | 8 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 211.878 SH | 8 de Agosto de 2026 | Diário |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,12% | 89.895 SH | 8 de Agosto de 2026 | Diário |
| IWN · iShares Trust | 0,12% | 1.117.630 SH | 8 de Agosto de 2026 | Diário |
| IJR · iShares Trust | 0,11% | 7.947.524 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 104.297 SH | 8 de Agosto de 2026 | Diário |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 455.144 SH | 8 de Agosto de 2026 | Diário |
| NUSC · Nushares ETF Trust | 0,10% | 135.666 NS | 30 de Abril de 2026 | N-PORT |
| IJS · iShares Trust | 0,09% | 489.210 SH | 8 de Agosto de 2026 | Diário |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,09% | 116.046 SH | 8 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,09% | 158.897 SH | 8 de Agosto de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 93.313 NS | 30 de Abril de 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 13.856 NS | 31 de Maio de 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 85.056 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,06% | 3.340.583 SH | 8 de Agosto de 2026 | Diário |
| ISCG · iShares Trust | 0,06% | 40.428 SH | 8 de Agosto de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 49.165 NS | 30 de Abril de 2026 | N-PORT |
| SAA · ProShares Trust | 0,06% | 1.546 NS | 31 de Maio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 757.699 SH | 8 de Agosto de 2026 | Diário |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 33.295 NS | 30 de Abril de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 1.728.845 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 106.278 NS | 31 de Maio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,04% | 55.874 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 6.071 NS | 31 de Maio de 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 5.811 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,03% | 388.986 SH | 8 de Agosto de 2026 | Diário |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 628.556 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 425.333 NS | 30 de Abril de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 14.399 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.492.431 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2.990.594 SH | 8 de Agosto de 2026 | Diário |
| UWM · ProShares Trust | 0,02% | 4.748 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 60.531 NS | 30 de Abril de 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 7.690 SH | 8 de Agosto de 2026 | Diário |
| SMLF · iShares Trust | 0,02% | 45.201 SH | 8 de Agosto de 2026 | Diário |
| URTY · ProShares Trust | 0,01% | 4.804 NS | 31 de Maio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 5.288 NS | 30 de Abril de 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 113.167 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.627 SH | 8 de Agosto de 2026 | Diário |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 5.219 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 339.840 NS | 30 de Abril de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 15.340 NS | 30 de Abril de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 121 NS | 31 de Maio de 2026 | N-PORT |